Gradual dose increases may also help support tolerability, as starting with a lower dose gives your system time to adjust before moving to higher levels
Across FDA-approved GLP-1 labels, nausea affects roughly 1244% of trial participants, and gastrointestinal symptoms cluster in the two to four weeks after each dose change which is exactly why side effects logged beside dose timing tell you more than side effects logged alone
It is administered as a once-weekly injection and is prescribed as part of a medically supervised program when clinically appropriate
1999;34:8389 Moy LA, Pfeffer MA, Wun CC, Davis BR, Geltman E, Hayes D, Farnham DJ, Randall OS, Dinh H, Arnold JM, et al
RETA and SEMA administration The study design is shown in Supplementary Fig
Sources and Further Reading Sarkar R